Jinbo YUE, Head of Department | Cited by 1,008 | of Shandong Cancer Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment), Jinan | Read 98 publications | Contact Jinbo YUE...

‪Shandong Cancer Hospital and Institute‬ - ‪‪Cited by 2,011‬‬

Dr. Jinbo Yue is a Professor of Radiation Oncology at Shandong Cancer Hospital and Institute where he specializes in abdominal cancers. He is currently serving as the Chair of Department of Radiation Oncology of Shandong Cancer Hospital and the Chief of 1st Abdominal Radiation Oncology of Shandong Cancer Hospital.

In this Research Topic, multiple studies investigate the role of RT in remodeling the immune TME. Gao et al. have identified three autophagy-related genes—SHC1, NAPSA, and AURKA—associated with RT and the prognosis of lung adenocarcinoma. NAPSA and AURKA were also closely associated with T H 2 cell infiltration.

2023年1月7日 · Using single-cell RNA sequencing, we revealed the intra- and intertumoral heterogeneity of epithelial cells in HPV + CEAD, providing insights into the importance of personalized treatment for patients with HPV + CEAD. The authors declare no conflict of interest.

2018年5月1日 · Electronic address: [email protected]. The standard treatment for locally advanced non-small cell lung cancer (LA NSCLC) includes surgery, radiotherapy, chemotherapy, or some combination of these modalities. Many clinical trials have been conducted in attempts to intensify treatment for LA NSCLC, but with little improvement.

Haohua Wang, Xiang Zhang, Jinbo Yue. Cureusno. 9 (2024): e69785-e69785. Cited 0 Views 0 WOS Bibtex. 0. 0. Feasibility and Safety of Contrast-Enhanced Magnetic Resonance-Guided Adaptive Radiotherapy for Upper Abdominal Tumors: A Preliminary Exploration. Wenheng Jiang, Xihua Shi, Xiang Zhang, Zhenjiang Li, Jinbo Yue.

Jinbo Yue practices in Jinan, China. Yue is highly rated in 1 condition, according to our data. Their top areas of expertise are Lung Metastases, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Cerebral Hypoxia. Their clinical research consists of co-authoring 73 peer reviewed articles in the past 15 years.

Concurrent chemoradiotherapy (CCRT) has been widely applied to locally advanced cervical cancer (LACC) patients, inducing the massive release of antigen and systematic immunomodulatory effects. However, its effect on the soluble immune checkpoint proteins (sICPs) remains unclear, which might play a key role in the immune response.

引言 肝切除是肝细胞癌 (HCC) 根治性治疗的中流砥柱，但术后 5 年复发率高达 70%，且主要 HCC 指南没有推荐可降低复发风险的辅助或新辅助治疗. 近十年来，HCC的全身治疗取得了重大进展，主要来自免疫检查点抑制剂（ICIs）和靶向治疗。 在其他恶性肿瘤中，新辅助环境中的 ICI 显示出比辅助环境更好的结果。 另一方面，在 ICI 中添加辐射会逐渐提高对 ICI 的全身反应。 ICI 的新辅助治疗加上立体定向放射治疗 (SBRT) 在几种类型的实体瘤中显示出有希望的结果，但在 …